Dorman Products (DORM) reported stronger Q3 results. Net sales were $543.7 million, up 7.9% year over year, and diluted EPS rose to $2.48 from $1.80. Gross margin expanded to 44.4% from 40.5%, lifting operating margin to 19.4% from 15.7% as tariff‑related price actions took effect before higher-cost inventory flowed through.
Interest expense fell to $7.2 million from $9.8 million on lower borrowings and rates. Light Duty led growth with $430.3 million in sales (up 9.3%) and higher profitability; Heavy Duty rose 5.7% on pricing and wins; Specialty Vehicle was slightly lower on demand. Year‑to‑date operating cash flow was $72.0 million versus $159.6 million, reflecting inventory investments and tariff timing, while inventories increased to $899.9 million.
The company noted that margins are expected to decrease in Q4 2025 as higher tariff costs are recognized. As of October 23, 2025, shares outstanding were 30,562,644.
Dorman Products (DORM) filed an 8-K announcing quarterly results communications. The company issued a press release with operating results for the third fiscal quarter ended September 27, 2025. It also scheduled a conference call and webcast on October 28, 2025, with access details provided in the press release attached as Exhibit 99.1.
Dorman Products (DORM) filing a Form 144 notifies the proposed sale of 144,000 common shares through Merrill Lynch, with an aggregate market value of $22,896,000 and approximate sale date of 09/16/2025 on NASDAQ. The filer reports these shares were originally acquired as founder stock on 01/29/1987 in exchange for an ownership interest, with payment characterized as equity. The filing also discloses a prior sale of 144,000 shares on 06/17/2025 for $19,923,096. The issuer's reported number of shares outstanding is 30,534,243. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Dorman Products, Inc. (DORM) Form 144 notice: An owner proposes to sell 72,000 shares of common stock through Merrill Lynch (Blue Bell, PA). The filing lists an aggregate market value of $11,346,000 and identifies the approximate sale date as 09/16/2025 on NASDAQ. The shares were originally acquired on 01/29/1987 as founder stock in exchange for an ownership interest in a partnership, with equity as the payment type. The filing also records a past sale of 72,000 shares by "S BERMAN 2005 TRUST" on 06/17/2025 for gross proceeds of $9,900,000. The filer attests they are not aware of undisclosed material adverse information.
Gregory C. Bowen, Vice President and Chief Accounting Officer of Dorman Products, Inc. (DORM), reported paired option exercise and stock sale transactions on 09/12/2025. The filing shows an employee stock option with an exercise price of $101.45 was exercised for 1,453 shares (transaction code M) and 1,453 shares were sold (transaction code S) at $162.808. After these transactions the report lists 4,658.9296 shares beneficially owned directly by Mr. Bowen. The option schedule notes the award vested in four equal annual installments beginning March 2, 2022. The Form 4 is signed by Frank J. Mahr by power of attorney on 09/15/2025.
Kathleen Pacheco, an officer (President, Specialty Vehicle) of Dorman Products, Inc. (DORM), reported a Section 16 transaction on 09/03/2025. The filing shows 134 shares were disposed of under code F at a price of $158.68 per share; the filer explains these shares were withheld by the issuer to satisfy tax withholding upon the vesting of restricted stock units. After the withholding, the reporting person beneficially owned 2,960 shares directly. The Form 4 was signed by Frank J. Mahr by power of attorney on 09/04/2025. No derivative transactions or other securities classes are reported in this filing.
Donna M. Long, SVP and Chief Information Officer of Dorman Products, Inc. (DORM), reported an acquisition on 08/14/2025 of 807 shares through an employee stock option transaction priced at $84.93 per share. Following the reported transaction, she beneficially owns 18,667.8738 shares directly. The filing notes the option grant originally covered 1,615 shares and vested in four equal annual installments beginning March 6, 2020. The Form 4 was signed by Frank J. Mahr by power of attorney on 08/18/2025.
Dorman Products insider sale: Donna M. Long, SVP and Chief Information Officer, reported the sale of 1,213 shares of Dorman Products, Inc. (DORM) on 08/12/2025 at a reported price of $150 per share. After this transaction she is shown as beneficially owning 17,860.8738 shares in a direct form. The Form 4 was signed by a power of attorney on 08/14/2025.
The Form 144 notice records a proposed sale of 113 common shares through Fidelity Brokerage Services LLC on NASDAQ, with an aggregate market value of $17,266.38 and an approximate sale date of 08/13/2025. The filing lists total shares outstanding as 30,534,243, so the proposed sale represents a very small fraction of the company’s outstanding stock. The securities to be sold were acquired by option grants dated 03/02/2022 and 03/02/2023 and payment is listed as cash.
The notice also discloses recent sales by Jeffrey Darby: 2,231 shares sold on 08/11/2025 for $317,597.63 and 9,191 shares sold on 08/12/2025 for $1,365,166.37. Key filing identifiers such as the issuer name and filer CIK are not present in the supplied text.
Dorman Products, Inc. (DORM) Form 144 reports a proposed sale of 9,191 common shares with an aggregate market value of $1,365,166.37, against approximately 30,534,243 shares outstanding, with an approximate sale date of 08/12/2025 on NASDAQ.
The notice details how the securities were acquired: restricted stock vesting (1,005; 1,987; 575 shares on 02/20/2025, 02/28/2025, 03/04/2025) and option-related acquisitions reported on 08/12/2025 (1,018; 1,998; 1,477; 1,131 shares) with payment described as compensation or cash. The filing also discloses a recent sale on 08/11/2025 by Jeffrey Darby of 2,231 shares for $317,597.63. The filer attests to having no undisclosed material adverse information.